Michael Sorich
Flinders University
H-index: 40
Oceania-Australia
Top articles of Michael Sorich
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials | Scientific Reports | Sara A Almansour Mohammad AY Alqudah Ziad Abuhelwa Humaid O Al-Shamsi Mohammad H Semreen | 2024/1/5 |
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation | Journal of Clinical Epidemiology | Ashley M Hopkins Natansh D Modi Frank W Rockhold Tammy Hoffmann Bradley D Menz | 2024/3/1 |
Special Paper: Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional … | The BMJ | Bradley D Menz Nicole M Kuderer Stephen Bacchi Natansh D Modi Benjamin Chin-Yee | 2024 |
Potential of Large Language Models as Tools Against Medical Disinformation—Reply | JAMA Internal Medicine | Ashley M Hopkins Bradley D Menz Michael J Sorich | 2024/2/26 |
Health disinformation use case highlighting the urgent need for artificial intelligence vigilance: weapons of mass disinformation | JAMA internal medicine | Bradley D Menz Natansh D Modi Michael J Sorich Ashley M Hopkins | 2024/1/1 |
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal … | British Journal of Cancer | CS Karapetis H Liu MJ Sorich LD Pederson E Van Cutsem | 2024/2/24 |
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials | BMC cancer | Lee X Li Mark A Socinski Ganessan Kichenadasse Christos S Karapetis Adel Shahnam | 2024/3/25 |
Immunotherapy for advanced non-small cell lung cancer with negative programmed death-ligand 1 expression: a literature review | Yibing Bai Wenyu Yang Lukas Käsmann Michael J Sorich Haitao Tao | 2024/2/2 | |
Quality and safety of artificial intelligence generated health information | BMJ | Michael J Sorich Bradley D Menz Ashley M Hopkins | 2024/3/20 |
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies | European Journal of Cancer | Adel Shahnam Nadia Hitchen Udit Nindra Sathya Manoharan Jayesh Desai | 2024/2/1 |
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis | bmj | Bradley D Menz Nicole M Kuderer Stephen Bacchi Natansh D Modi Benjamin Chin-Yee | 2024/3/20 |
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies | BMC medicine | Natansh D Modi Ganessan Kichenadasse Tammy C Hoffmann Mark Haseloff Jessica M Logan | 2023/10/23 |
Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis. | Natansh Modi Ahmad Y Abuhelwa Andrew Rowland Bradley D Menz Ross Allan McKinnon | 2023/6/1 | |
Understanding the risk of drug interactions between ritonavir-containing COVID-19 therapies and small-molecule kinase inhibitors in patients with cancer | JCO Precision Oncology | Ashley M Hopkins Michael J Sorich Andrew J McLachlan Christos S Karapetis John O Miners | 2023/2 |
231P Time to deterioration of quality of life as a surrogate of OS: A trial-level surrogacy analysis | Annals of Oncology | A Shahnam U Nindra J Desai R Hui AM Hopkins | 2023/10/1 |
Low risk of hyperprogression with first-line chemoimmunotherapy for advanced non-small cell lung cancer: pooled analysis of 7 clinical trials | The oncologist | Lee X Li Federico Cappuzzo Ignacio Matos Mark A Socinski Ashley M Hopkins | 2023/4/1 |
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer | Pathology | Carmela Martini Jessica M Logan Alexandra Sorvina Colin Gordon Andrew R Beck | 2023/2/1 |
Survival outcomes for patients with colorectal cancer with synchronous liver only metastasis | ANZ Journal of Surgery | Mia Shepherdson Daniel Kilburn Shahid Ullah Timothy Price Christos S Karapetis | 2023/7 |
Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs | Rheumatology | Dala N Daraghmeh Ashley M Hopkins Catherine King Ahmad Y Abuhelwa Mihir D Wechalekar | 2023/2/1 |
Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift | JNCI Cancer Spectrum | Ashley M Hopkins Jessica M Logan Ganessan Kichenadasse Michael J Sorich | 2023/4/1 |
Co-Authors
